Definium Therapeutics, Inc. Gain (Loss) on Extinguishment of Debt
Definium Therapeutics, Inc. (DFTX) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-26
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $2.54M.
- Definium Therapeutics, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $2.54M derived: sum of 3 quarters · filed 2026-02-26 | $2.54M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.54M derived: sum of 2 quarters · filed 2025-11-06 | $2.54M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $2.54M 10-Q · filed 2025-07-31 | $2.54M 10-Q · filed 2025-07-31 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |